AVIR position history
The shares of Atea Pharmaceuticals (AVIR) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 359,630 shares, $1.3M, 0.17% of portfolio, New
- 2026 Q1: 322,600 shares, $1.7M, 0.23% of portfolio, Reduce −10.3%
- 2026 Q2: 235,000 shares, $1.1M, 0.10% of portfolio, Reduce −27.2%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|